DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

86.06 1.65 −1.88%
Market cap
$33.1B
P/E
33.2×
Fwd P/E
29.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a

DexCom, Inc. (DXCM) Operating margin

Alert me on Operating margin

DexCom, Inc.'s operating margin over the twelve months to 30 June 2026 was 22.9%, up 3.4 percentage points from fiscal 2025 (19.6%). Over the past ten years it has ranged from −18.1% (fiscal 2018) to 19.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 19.6% 4.68
FY2024 14.9% (1.62)
FY2023 16.5% 3.06
FY2022 13.4% 2.58
FY2021 10.9% (4.68)
FY2020 15.5% 5.90
FY2019 9.64% 27.70
FY2018 −18.1% (12.14)
FY2017 −5.92% 5.23
FY2016 −11.2% 3.05

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 24.3% 2.91
Mar 2026 21.4% (4.22)
Dec 2025 25.6% 5.59
Sep 2025 20.1% 1.68
42 more quarters

Against its own ten years

Low −18.1% High 19.6%
Ten-year median 10.9%
Current reading's percentile 100

Operating margin against peers

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on DXCM